Brendan Clark

8PUBLICATIONS

12CO-AUTHORS

Cardiology (incl. cardiovascular diseases)Medical virologyPharmacogenomicsPsycholinguistics (incl. speech production and comprehension)Cancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 30, 2026

Clinical and Economic Burden Following Percutaneous Coronary Intervention for STEMI: A US Real-World Evidence Study.

|Oct 01, 2025

Comparable Clinical Outcomes with Tiotropium/Olodaterol or Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with COPD and Blood Eosinophil Count ≤300 Cells/μL.

Sanjay Sethi, Brendan Clark, Erin K Buysman

|Sep 19, 2025

Obesity Medication Treatment Perspectives Among People with Overweight or Obesity.

John W Ostrominski, Anindit Chhibber, Effie L Kuti

|Feb 19, 2025

Clinical and Economic Evaluation of Fluticasone Furoate/Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol Therapy in Maintenance Treatment-Naive Patients with COPD in the US.

Asif Shaikh, John Ritz, Julian Casciano

|Nov 07, 2023

Fanconi Syndrome in Patients With Human Immunodeficiency Virus Treated With Tenofovir-Based Antiretroviral Therapy: A Systematic Literature Review.

Mrinmayee Joshi, Brendan Clark, Todd A Lee

|May 08, 2023

Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation History.

Sanjay Sethi, Brendan Clark, Lindsay G S Bengtson

Pageof 2

Frequent Collaborators

Bonnie M K Donato

Sanjay Sethi

Asif Shaikh

Jill A Ohar

Elisabeth Sophia Hartgers-Gubbels

Mrinmayee Joshi

Jennifer K Quint

Erin K Buysman

Andrew Sargent

Lindsay G S Bengtson

Frequent Collaborators

Bonnie M K Donato

Sanjay Sethi

Asif Shaikh

Jill A Ohar